Amneal Pharmaceuticals (AMRX) Goodwill & Intangibles (2017 - 2026)

Amneal Pharmaceuticals' Goodwill & Intangibles history runs 10 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• On a quarterly basis, Goodwill & Intangibles fell 12.28% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 12.28% decrease from a year earlier, with the FY2025 full-year figure at $1.2 billion, down 12.85% from the prior year.
• Goodwill & Intangibles slipped to $1.1 billion in Q1 2026 per AMRX's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $1.8 billion in Q1 2022 and bottomed at $1.1 billion in Q1 2026.
• The 5-year median for Goodwill & Intangibles is $1.5 billion (2024), against an average of $1.5 billion.
• Across the five-year window, Goodwill & Intangibles grew 1.51% in 2022 and declined 14.12% in 2025, its largest moves.
• Year by year, Goodwill & Intangibles stood at $1.7 billion in 2022, then decreased by 12.15% to $1.5 billion in 2023, then dropped by 10.69% to $1.3 billion in 2024, then retreated by 12.85% to $1.2 billion in 2025, then retreated by 2.61% to $1.1 billion in 2026.
• Per Business Quant, the three latest AMRX Goodwill & Intangibles figures stand at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025).